GleamWall
中文EN

DGX QUEST DIAGNOSTICS INC

Services-Medical Laboratories · NYSE · SEC CIK 1022079 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.1%
TTM net income YoY16.5%
TTM EPS YoY17.8%
Revenue 3-yr CAGR8.4%
Net income 3-yr CAGR14.0%

Margins

Gross margin33.1%
Operating margin14.6%
Net margin9.5%
FCF margin11.6%
EBITDA margin19.5%

Returns

ROE15.2%
ROA6.8%
ROIC (approx.)10.7%
Asset turnover0.71x

Leverage & solvency

Liabilities / assets53.4%
Debt / equity0.73x
Current ratio1.70x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.73x
Accruals ratio-4.9%
Payout ratio32.7%
Capex / revenue4.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$3.10B$3.04B$2.90B$2.81B$2.82B$2.76B$2.65B$2.62B
Cost of revenue$2.06B$2.02B$1.95B$1.90B$1.87B$1.82B$1.79B$1.76B
Gross profit$1.04B$1.03B$942.00M$910.00M$949.00M$943.00M$863.00M$858.00M
SG&A expense$523.00M$529.00M$504.00M$504.00M$501.00M$486.00M$476.00M$466.00M
Operating income$479.00M$459.00M$399.00M$386.00M$386.00M$438.00M$346.00M$361.00M
Pretax income$416.00M$412.00M$334.00M$330.00M$328.00M$384.00M$276.00M$299.00M
Income tax$99.00M$88.00M$74.00M$81.00M$77.00M$97.00M$59.00M$68.00M
Net income$312.00M$320.00M$252.00M$245.00M$245.00M$282.00M$220.00M$222.00M
EBITDA$626.00M$605.00M$546.00M$531.00M$528.00M$581.00M$486.00M$496.00M
EPS (basic)2.822.882.27—2.182.511.97—
EPS (diluted)2.782.842.24—2.162.471.94—
Dividends declared per share0.860.860.860.800.800.800.800.75
Weighted avg. shares (diluted)112.00M112.00M112.00M—113.00M113.00M113.00M—
Banking
Net interest income-$61.00M-$63.00M-$63.00M-$64.00M-$66.00M-$67.00M-$67.00M-$65.00M
Balance sheet
Cash & equivalents$797.00M$626.00M$393.00M$420.00M$432.00M$319.00M$188.00M$549.00M
Receivables$1.71B$1.67B$1.59B$1.41B$1.46B$1.42B$1.40B$1.30B
Inventory$218.00M$233.00M$225.00M$189.00M$186.00M$187.00M$189.00M$188.00M
Current assets$3.12B$2.84B$2.57B$2.38B$2.41B$2.20B$2.08B$2.39B
PP&E, net$2.27B$2.22B$2.19B$2.20B$2.15B$2.12B$2.10B$2.11B
Goodwill$9.11B$9.11B$9.12B$8.95B$8.90B$8.88B$8.85B$8.86B
Intangibles$1.63B$1.67B$1.72B$1.64B$1.66B$1.71B$1.73B$1.76B
Total assets$17.22B$16.94B$16.67B$16.23B$16.20B$15.97B$15.80B$16.15B
Current liabilities$1.83B$1.79B$2.18B$2.28B$2.13B$2.02B$1.44B$2.17B
Short-term debt$10.00M$10.00M$503.00M$504.00M$504.00M$504.00M$1.00M$602.00M
Long-term debt$5.54B$5.63B$5.16B$5.17B$5.17B$5.17B$5.86B$5.62B
Total debt$5.55B$5.64B$5.66B$5.67B$5.67B$5.67B$5.86B$6.22B
Total liabilities$9.19B$9.04B$8.93B$8.94B$8.82B$8.62B$8.75B$9.26B
Shareholders' equity$7.63B$7.52B$7.37B$7.17B$7.26B$7.23B$6.93B$6.78B
Net debt$4.75B$5.02B$5.26B$5.25B$5.24B$5.35B$5.67B$5.67B
Cash flow statement
Operating cash flow$611.00M$597.00M$278.00M$465.00M$563.00M$544.00M$314.00M$464.00M
Capital expenditure$166.00M$138.00M$114.00M$158.00M$144.00M$108.00M$117.00M$123.00M
Free cash flow$445.00M$459.00M$164.00M$307.00M$419.00M$436.00M$197.00M$341.00M
Investing cash flow-$169.00M-$134.00M-$152.00M-$191.00M-$201.00M-$124.00M-$115.00M-$502.00M
Financing cash flow-$271.00M-$229.00M-$152.00M-$287.00M-$247.00M-$293.00M-$561.00M-$170.00M
Depreciation & amortization$147.00M$146.00M$147.00M$145.00M$142.00M$143.00M$140.00M$135.00M
Stock-based compensation$20.00M$23.00M$20.00M$25.00M$20.00M$21.00M$22.00M$27.00M
Dividends paid$95.00M$96.00M$88.00M$90.00M$89.00M$90.00M$84.00M$84.00M
Share buybacks$150.00M——$300.00M$150.00M——$151.00M

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.